Surfactant replacement therapy, respiratory support, in addition to optimal neonatal care and management of complications (e.g. pneumothorax) limit the duration and severity of HMD. Respiratory support might be in the form of oxygen therapy, CPAP or mechanical ventilation in severe HMD when non-invasive support is ineffective in maintaining gas exchange.
